BWGIC Activity report 2014

Similar documents
What do the guidelines say?

Σεμινάριο Ομάδων Εργασίας Fractional Flow Reserve (FFR) Σε ποιούς ασθενείς; ΔΗΜΗΤΡΗΣ ΑΥΖΩΤΗΣ Επιστ. υπεύθυνος Αιμοδυναμικού Τμήματος, Βιοκλινική

Evolution In Interventional Cardiology. Jawed Polad Jeroen Bosch Hospital s-hertogenbosch The Netherlands

Registry and benchmarking as tool for Quality assessment in STEMI patients

Clinical case in perspective. Cases from Poland

Paris, August 28 th Gian Paolo Ussia on behalf of the CoreValve Italian Registry Investigators

Version 4.4. Institutional Outcomes Report 2014Q3. National Outcomes Report Aggregation Date: Jan 12, :59:59 PM

Relations of Interest

VCU Pauley Heart Center: A 2009 US News Top 50 Heart and Heart Surgery Hospital

Emergency surgery in acute coronary syndrome

3 Year Clinical Outcome and Cost-Effectiveness of FFR- Guided PCI in Stable Patients with Coronary Artery Disease: FAME 2 Trial

La FFR quoi d autre: En pratique? Pierre Deharo, CHU TIMONE, Marseille

Ruhr-University Bochum, Germany. Ev. Stift St. Martin, Koblenz, Germany. Premier Heart, Port Washington, NY, USA

Imaging ischemic heart disease: role of SPECT and PET. Focus on Patients with Known CAD

How to approach non-infarct related artery disease in patients with STEMI in a limited resource setting

PCIs on Intermediate Lesions NCDR Cath-PCI Registry

FFR and CABG Emanuele Barbato, MD, PhD, FESC Cardiovascular Center Aalst, Belgium

Approach to Multi Vessel disease with STEMI

Cardiac Care Network of Ontario

Zachary I. Hodes, M.D., Ph.D., F.A.C.C.

TAVR and Cardiac Surgeons

Elections to EACVI Board and Sections

FRACTIONAL FLOW RESERVE: STANDARD OF CARE

CABG vs PCI: What do the Guidelines Say?

Cardiologic history. Anamnesis. Female BD Risk factors HTN, DM, Dyslipidaemia. Cardiologic Long history. Last admission Heart failure

Mode of admission and its effect on quality indicators in Belgian STEMI patients

Surgeon Involvement in Transcatheter Valve Therapy

PCI Update Qesaria 2009

Coronary interventions

Valve Disease in Patients With Heart Failure TAVI or Surgery? Miguel Sousa Uva Hospital Cruz Vermelha Lisbon, Portugal

Summary Transcatheter aortic valve implantation: Evaluation of the evidence and synthesis of organizational issues

Indication, Timing, Assessment and Update on TAVI

Clinical Commissioning Policy: Transcatheter Aortic Valve Implantation (TAVI) For Aortic Stenosis. December Reference : NHSCB/A10/a/1

Peer review in Arhythmology The BeHRA databases

Fractional Flow Reserve. A physiological approach to guide complex interventions

CLINICAL CONSEQUENCES OF THE

Evaluation of Intermediate Coronary lesions: Can You Handle the Pressure? Jeffrey A Southard, MD May 4, 2013

Master Class in Preventive Cardiology Focus on Diabetes and Cardiovascular Disease Geneva April

Nurse-led Rapid Access Chest Pain Clinic at the Royal Glamorgan Hospital. by Sharon Cassidy/Andrea Gasson

The VGH Interventional Cardiology Fellowship program has successfully trained 38 interventional fellows since 1993.

Trans-catheter aortic valve implantation (TAVI) work up

CONTEMPORARY USE OF ARTERIAL GRAFTS DURING CORONARY ARTERY BYPASS SURGERY: PARADIGM SHIFT? OR A LITTLE (MORE) TALK THAT NEEDS A LOT MORE ACTION

Ray Matthews MD Professor of Clinical Medicine Chief of Cardiology University of Southern California

PCI for Stable Ischemic Heart Disease: What Happened in the Last Week?

Percutaneous coronary intervention of RIMA. The real challenge!

Benefit of Performing PCI Based on FFR

A European Quality Assurance Scheme for Breast Cancer Services - updates Joint Research Centre

National Cardiovascular Data Registry

Solving the Dilemma of Ostial Stenting: A Case Series Illustrating the Flash Ostial System

Incidence and Management of Early Implant Failure after Transcatheter Aortic Valve Implantation

Coronary angiography and PCI

Percutaneous Management of Severe AS in Octagenarians. Phillip Matsis FRACP FCSANZ Interventional Cardiologist Wakefield Heart Centre Wellington

Δημήτριος Αγγοσράς, FETCS

Case Report Left Main Stenosis. Percutaneous Coronary Intervention (PCI) or Coronary Artery Bypass Graft Surgery (CABG)?

Percutaneous Aortic Valve Implantation. Core-Valve and Cribier-Edwards Update

IPAC date: May of 13

Dave Kettles, St Dominics Hospital East London.

National Intervention Council

Percutaneous Coronary Interventions Without On-site Cardiac Surgery

Patient with low-flow low-gradient aortic stenosis and ischemic cardiomyopathy TAVR and possibly percutaneous revascularization

Advances in Cardiovascular Diagnosis and Therapy. No disclosure or conflicts. Outline

FFR in Multivessel Disease

TAVI SURVEY. Performed by the ESC Council for Cardiology Practice

EXCEL vs. NOBLE: How to Treat Left Main Disease in 2017 AATS International Cardiovascular Symposium December 8-9, 2017

Pathology of percutaneous interventions (PCI) in coronary arteries. Allard van der Wal, MD.PhD; Pathologie AMC, Amsterdam, NL

Alex versus Xience Registry Preliminary report

Lessons learned From The National PCI Registry

The Impact of TAVI Nurse Coordinator on patient management of Transcatheter Aortic Valve Implantation (TAVI) program in QEH

Aortic Valve Practice Guidelines: What Has Changed and What You Need to Know

Making the difference with Live Image Guidance

Update interventional Cardiology Hans Rickli St.Gallen

Peter F Ludman BCIS National Audit Lead

Results Presentation 2Q FY March Win-Partners Co., Ltd. (3183)

J. Schwitter, MD, FESC Section of Cardiology

The ACC 50 th Annual Scientific Session

procedures for severe Aortic stenosis Treatment

Do stents deserve the bad press? Mark A. Tulli MD, FACC

Participating Hospitals & Publicly Released COAP Data

Summary HTA. Drug-eluting stents vs. coronary artery bypass-grafting. HTA-Report Summary. Gorenoi V, Dintsios CM, Schönermark MP, Hagen A

There s Triple Vessel Disease and Triple Vessel Disease: Risk Assessment

The Evolving ACC-NCDR Programs: What you need to know for your practice

In Process, Unpublished STS/ACC TVT Registry Manuscripts

Centers for Medicare and Medicaid Services. National Coverage of Transcatheter Valve Technologies December 2015

Declaration of conflict of interest. Nothing to disclose

CathPCI Registry Poster Abstract

Setting The setting was a hospital. The economic study was carried out in Australia.

TREATMENT OF HIGHER RISK PATIENTS INTRODUCTION TO PROTECTED PCI WITH IMPELLA. IMP v4

Trends in reperfusion therapy of STEMI patients in Belgium for the period

8. Nov, 2018 Athens Clossroad 2018, Athens GREEK

Title:Relation Between E/e' ratio and NT-proBNP Levels in Elderly Patients with Symptomatic Severe Aortic Stenosis

The American College of Cardiology/American Heart

in an Unyielding Patient Dr Jason See, Dr Goh Yew Seong, Dr Rohit Khurana Changi General Hospital Singapore

Policy Specific Section: March 30, 2012 March 7, 2013

Critical Appraisal of Risk Adjusted Analysis and Public Reporting of Outcomes in Cardiac Surgery

Coronary Artery Disease: Revascularization (Teacher s Guide)

STEMI Management in Belgium

Update 2012 Herzchirurgie

Resolute in Bifurcation Lesions: Data from the RESOLUTE Clinical Program

Data Requirements. Accreditation for Cardiovascular Excellence Quality in Invasive Cardiovascular Care

Neovasc Inc. Alexei Marko, CEO. June 2011

Transcription:

BWGIC Activity report 2014 Quality control in percutaneous coronary intervention (PCI) and trans-catheter aortic valve implantation (TAVI) The project was to contribute to control and to improve the quality in interventional cardiology. Two types of interventional procedures with proven clinical efficacy were more particularly evaluated: PCI and TAVI. PCI PCI (percutaneous coronary intervention) is a well-established interventional procedure that represents the routine historical activity of B2 and B2/B3 centers. This activity is monitored by the BWGIC since 1996, but the transfer of the database from BWGIC to QERMID in 2012 has considerably modified the practicability and the quality of this peer review. In 2014, the BWGIC organized a peer review of PCI activity performed in 2013 oriented toward: -collection of a minimal data set of activity parameters from all centers -evaluation of the appropriateness of PCI in a (random) sample of 10 centers Results of this peer review are reported below. Obviously and unfortunately, due to the impossibility to extract data from QERMID, this peer review requested considerably more efforts and provided less information than similar peer reviews performed in previous years when the database was owned by the BWGIC. Additionally, representatives of the BWGIC actively participated to discussions with the QERMID team in 2014 in order to optimize the quality of data entered in the QERMID database, to improve the transfer of data (system to system connections) and to develop applications allowing extraction of data and benchmarking. Unfortunately, to date (June 2015) no access to any data is provided to BWGIC or to the College of Cardiology. TAVI TAVI (trans-catheter aortic valve implantation) is performed in most interventional centers although partial reimbursement is restricted to a limited number of centers in selected situations. From the beginning of this activity, a Belgian data base has been developed on a voluntary basis. As it was done previously for PCI, the BWGIC wanted to move to a web-based application allowing collection of data from all centers ; the objective is to collect data from all TAVI procedures (whether

reimbursed or not) in order to evaluate the progression of the technique in Belgium, the selection of patients, quality indicators and patients outcome. BWGIC has created a percutaneous valve task force that actively collaborated with the Belgian association for cardiothoracic surgery (BACTS). The items to be collected were discussed and a digital platform was developed in collaboration with Lambda+. This platform was presented to representatives of INAMI/RIZIV. Completion of database is linked to (partial) reimbursement for the selected centers but all centers (including those that are not selected for conditional reimbursement) are encouraged to enter their data. An interim report will be presented to INAMI/RIZIV by the BWGIC and BACTS in December 2015.

Peer review of PCI in Belgium History of PCI peer review The Belgian working group on interventional cardiology (BWGIC) of the Belgian society of cardiology took the initiative to collect data from interventional procedures since 1996. Data collection was done by fax in the first years (1996-2003) then in a web-database hosted by the European society of cardiology from 2003 to2012. This data base allowed extensive peer review and benchmarking with other Belgian and European centers. In 2012, the PCI database that was previously managed by the BWGIC was transferred to the QERMID system. Among the promises linked to this transfer was the possibility of a validation of mid- and long-term mortality data by a link with national registry. The absence of validation of mortality was indeed a weak point of the previous database that otherwise allowed extensive statistics, peer review and benchmarking between centers in Belgium and in Europe. Early after this transfer, the BWGIC was informed that the QERMID application had been launched without any possibility to extract data, making peer review and -even basiccounting or statistics impossible. Three years later, very few progresses have been made from QERMID and BWGIC is still waiting for the possibility to obtain information about PCI activity. Even a simple request such as the number of PCI done in Belgium could not be fulfilled. Discussions between representatives of BWGIC and QERMID are underway to improve this situation. Methods The board of BWGIC decided to organize under two aspects: 1. Collection of basic data on 2013 PCI activity in each center: Number of Coronary angiograms in 2013 Number of PCI procedures in 2013 Number of FFR measurements done (total number of cases in 2013) Number of urgent CABG after PCI (unscheduled CABG surgery within 48 hours of PCI for failure or complication or incomplete result of the index procedure) Number of interventional cardiologists having done >100 PCI/year in 2013 2. Review of 10 clinical dossiers from 10 centers addressing the appropriateness of PCI.

Selection of centers and of patients was done randomly. All centers were contacted by email; all did provide the requested information. Main information 1. Collection of basic data on 2013 PCI activity Number of Coronary angiograms in 2013 63422 Number of PCI procedures in 2013 24230 Number of FFR measurements done (total number of cases in 2013) Number of urgent CABG after PCI (unscheduled CABG surgery within 48 hours of PCI for failure or complication or incomplete result of the index procedure) Number of interventional cardiologists having done >100 PCI/year in 2013 5579 86 120 2. Appropriateness of PCI All dossiers and angiograms were reviewed. The 100 PCI procedures included 49 stables angina and 51 acute coronary syndromes (25 STEMIs). 105 segments were dilated; PCI was successful in 98/105 segments. A PCI was considered clinically justified in two situations: Angina OR positive non-invasive test of ischemia AND stenosis >50% Stenosis >70% OR FFR <0.80 independently of symptoms or signs of ischemia Among the 105 dilated segments, 94 were clinically justified; for 11 segments, PCI was either not justified or incompletely documented. This proportion could probably be further reduced by a more extensive review of clinical dossiers that would require a site visit. Overall, the FFR seems underused in some borderline situations. Insufficiency of FFR reimbursement is the most likely explanation for this finding. Specifically, in patients with stable angina (or equivalent) a non-invasive test for ischemia was performed in 25/49 (negative test in 6 of them) and not done in 24/49. The majority of elective PCI was thus performed without objective proof of ischemia (although not all of them inappropriately).

Future developments and expected improvements BWGIC hopes that access to QERMID data will be available in the next months. This will provide feedback to centers on their activity and allow benchmarking and quality control. A link with official mortality data would be essential to validate long-term outcome. An estimation of mid-term and long-term mortality based on spontaneous report by the cardiologist is unrealistic and unreliable. Future adaptations and upgrades in the QERMID database should only be made in close collaboration with BWGIC representatives. Prof Claude Hanet Project coordinator Email: claude.hanet@uclouvain.be